These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

101 related articles for article (PubMed ID: 13971143)

  • 1. [Cerebral nutrition and possibilities of its improvement].
    BIRKMAYER W; HAWLICZEK F; SEEMANN D
    Munch Med Wochenschr; 1962 Nov; 104():2246-8. PubMed ID: 13971143
    [No Abstract]   [Full Text] [Related]  

  • 2. [CLINICO-ELECTROENCEPHALOGRAPHIC FINDINGS IN VASOACTIVE TREATMENT WITH COMPLAMIN].
    FLUEGEL KA; MENGI E; CORA R
    Med Klin; 1964 Nov; 59():1831-5. PubMed ID: 14330837
    [No Abstract]   [Full Text] [Related]  

  • 3. [Drug therapy of cerebral circulation disorders].
    GARNIER B
    Schweiz Med Wochenschr; 1963 Jan; 93():176-9. PubMed ID: 13960458
    [No Abstract]   [Full Text] [Related]  

  • 4. [CONSIDERATIONS ON CEREBRAL HEMODYNAMICS THROUGH COMPARATIVE RHEOGRAPHIC AND ELECTROENCEPHALOGRAPHIC EXAMINATIONS. III. ACTIVITY OF NICOTINIC ACID IN SUBJECTS HAVING CEREBROVASCULAR DISEASES].
    DELGUERCIO R
    Riforma Med; 1963 Sep; 77():1004-7. PubMed ID: 14092203
    [No Abstract]   [Full Text] [Related]  

  • 5. [Acute arrest of the retinal circulation eliminated by intravenous administration of Complamin].
    Thomalske G; Manz R
    Med Klin; 1967 Jan; 62(3):98 passim. PubMed ID: 6031752
    [No Abstract]   [Full Text] [Related]  

  • 6. [ON THE TREATMENT OF CEREBRAL AND PERIPHERAL CIRCULATORY DISORDERS. (REPORT ON CLINICAL EXPERIENCES WITH COMPLAMIN)].
    LOOS M
    Med Welt; 1964 Aug; 32():1710-2. PubMed ID: 14291150
    [No Abstract]   [Full Text] [Related]  

  • 7. [A CASE OF THE OCCLUSION OF THE ANTERIOR CEREBRAL ARTERY].
    TERAOKA H; MIMURA K; YAMAGATA M; HARADA M; TAKAKI M
    Kumamoto Igakkai Zasshi; 1963 Jul; 37():423-6. PubMed ID: 14080852
    [No Abstract]   [Full Text] [Related]  

  • 8. [STENOSIS AND THROMBOSIS OF THE MAJOR BLOOD VESSELS OF THE HEAD].
    STOK VN
    Lek Veda Zahr; 1963 Oct; 10():193-7. PubMed ID: 14108612
    [No Abstract]   [Full Text] [Related]  

  • 9. [CLINICAL TRIAL OF A NEW NICOTINIC ACID DERIVATIVE, MESO-INOSITOL-HEXANICOTINATE, IN NEUROPSYCHIATRY].
    NAKAZAWA T; KABESHIMA A; SAITO M; UUCHI Y; NAKAHARA M
    No To Shinkei; 1963 Sep; 15():902-9. PubMed ID: 14045318
    [No Abstract]   [Full Text] [Related]  

  • 10. THE PATHOGENESIS OF CEREBRAL VASCULAR DISEASE.
    TADROS FW; HIGAZI AM; ZAKI SA
    Br J Clin Pract; 1964 Mar; 18():125-32. PubMed ID: 14130455
    [No Abstract]   [Full Text] [Related]  

  • 11. [COMPARATIVE ANALYSIS OF THE VASCULAR EFFECTS OF 3-(METHYL-OXYETHYLAMINE)-2-OXYPROPYL-THEOPHYLLINE NICOTINATE, NICOTINIC ACID AND THEOPHYLLINE].
    DEGREGORIO G; BUDA A; FIDECARO A
    Riforma Med; 1964 Aug; 78():937-41. PubMed ID: 14222308
    [No Abstract]   [Full Text] [Related]  

  • 12. [ON ELECTRORHEOGRAPHIC OBJECTIVE EVALUATION OF SUBSTANCES WITH CENTRAL NERVOUS SYSTEM ACTION. SODIUM NICOTINATE AND SODIUM BETA,BETA-PENTAMETHYLENE-GAMMA-HYDROXYBUTYRATE MONOHYDRATE].
    KUNERT W; DUNKER R
    Arzneimittelforschung; 1963 Nov; 13():986-8. PubMed ID: 14210439
    [No Abstract]   [Full Text] [Related]  

  • 13. [On the effects of drugs on the cerebral vessels].
    GLONING K; KLAUSBERGER EM
    Wien Klin Wochenschr; 1959 Nov; 71():880-3. PubMed ID: 13828490
    [No Abstract]   [Full Text] [Related]  

  • 14. [CLINICAL TESTING OF MESO-INOSITOL-HEXANICOTINATE].
    OKADA Y; HANADA M; SUGIURA Y
    No To Shinkei; 1963 Nov; 15():1081-5. PubMed ID: 14096451
    [No Abstract]   [Full Text] [Related]  

  • 15. [Cerebral angiodynamic effects of nicotinic acid in man. (Polygraphic and angiographic studies)].
    Corsi C; Spinelli P
    Rass Neurol Veg; 1967 Dec; 21(6):337-52. PubMed ID: 5608551
    [No Abstract]   [Full Text] [Related]  

  • 16. [ON COMPLAMIN].
    JENSEN BS
    Ugeskr Laeger; 1963 Aug; 125():1167-70. PubMed ID: 14045855
    [No Abstract]   [Full Text] [Related]  

  • 17. [The treatment of acute cerebrovascular disorders by the nicotinic acid ester of 7-(2-hydroxyethyl)-theophylline (hesotin)].
    BARTOUSEK V; CERNY J; DUBANSKY B
    Ther Umsch; 1960 May; 17():182-5. PubMed ID: 13797315
    [No Abstract]   [Full Text] [Related]  

  • 18. [ON THE TREATMENT OF APOPLEXY WITH COMPLAMIN (7-(2-HYDROXY-3-(N-2-HYDROXYETHYL-N-METHYLAMINO)PROPYL)THEOPHYLLINE NICOTINATE].
    FRUHMANN H
    Med Welt; 1963 Oct; 41():2084-7. PubMed ID: 14134155
    [No Abstract]   [Full Text] [Related]  

  • 19. [Administration of nicotinic acid in cerebral circulatory disorders, especially in states following apoplexy with hemiplegia].
    MENTHA J; STEPONAVICIUS J
    Helv Med Acta; 1951 Dec; 18(6):608-31. PubMed ID: 14897342
    [No Abstract]   [Full Text] [Related]  

  • 20. [Angioscintigraphy and angiography in the study of vascular and cerebral pharmacodynamics].
    Pratesi F; Corsi C; Pollastri M; Masi R; Pesciullesi E
    Acta Neurol (Napoli); 1974 Mar; 29(2):147-58. PubMed ID: 4211297
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 6.